Moreover, counteraction of the lidocaine effect [60] (i.e., lidocaine occupied receptors on the sodium channel in its open/active (phase 0) and inactivated/refractory (phase 2) states [280]) can suggest that, as lidocaine, BPC 157 itself can have a high affinity for its receptors during both phases
In animal studies, tissue healing improvements have been observed within 12 weeks, with more significant results documented at 24 weeks depending on the injury model
Not approved for human consumption, veterinary use, or clinical application.
For instance, it serves as a treatment for pernicious anemia
Product quality explains many of these failures, but some individuals simply do not respond to the peptide regardless of source or protocol
Pharmaceuticals, 16(5), 676